Originally published by Robert Kraft.
In continuing coverage, Bloomberg News reported that a former GlaxoSmithKline executive has filed a whistleblower lawsuit claiming “he was fired for pointing out flaws in studies used to tout the benefits of the drugmaker’s Nicoderm [nicotine] line of smoking-cessation products.” Alexandre Selmani claims he was terminated after pointing out flaws in studies supporting the product and alleges that GSK illegally marketed the product as superior to competitor products.
From the news release of the American Association for Justice.
Curated by Texas Bar Today. Follow us on Twitter @texasbartoday.
from Texas Bar Today http://ift.tt/1UyimpT
via Abogado Aly Website
No comments:
Post a Comment